Study of Serum YKL-40 Level and Impaired Glucose Tolerance Combined With Cardiovascular Diseases Risk

Heart - United Kingdom
doi 10.1136/heartjnl-2011-300867.347
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Impaired Glucose Tolerance, Impaired Fasting Glucose, and Cardiovascular Risk

Circulation Journal
MedicineCardiovascular MedicineCardiology
2007English

Evaluation of Total Cardiovascular Risk in Patients With Hypertension and Impaired Glucose Tolerance

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
2017English

Serum YKL-40 and Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
1999English

Bruselloz Hastalarında Serum YKL-40 Düzeylerinin Belirlenmesi

Turkish Journal of Clinics and Laboratory
2019English

Impaired Fasting Glucose and Impaired Glucose Tolerance in Women With Prior Gestational Diabetes Are Associated With a Different Cardiovascular Profile

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

Impaired Glucose Tolerance and Height.

BMJ
1991English

YKL-40 - An Emerging Biomarker in Cardiovascular Disease and Diabetes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2009English

Serum YKL-40 and Interleukin 6 Levels in Hodgkin Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Associations of Green Tea and Rock Tea Consumption With Risk of Impaired Fasting Glucose and Impaired Glucose Tolerance in Chinese Men and Women

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy